Brett Fishbin
Stock Analyst at KeyBanc
(1.76)
# 3,468
Out of 5,126 analysts
130
Total ratings
51.9%
Success rate
0.1%
Average return
Main Sectors:
Stocks Rated by Brett Fishbin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICUI ICU Medical | Reiterated: Buy | $164 → $189 | $178.26 | +6.02% | 18 | Nov 6, 2026 | |
| KE Kimball Electronics | Reiterated: Hold | n/a | $19.53 | - | 2 | Nov 6, 2026 | |
| STE STERIS | Reiterated: Buy | $269 → $284 | $256.27 | +10.82% | 9 | Nov 6, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Hold | n/a | $79.29 | - | 12 | Nov 5, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | n/a | $62.11 | - | 18 | Nov 3, 2026 | |
| RMD ResMed | Reiterated: Buy | $267 → $277 | $238.53 | +16.13% | 19 | Oct 30, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 72.64 → CHF 69.34 | CHF 59.48 | +16.57% | 10 | Oct 27, 2026 | |
| NPCE NeuroPace | Initiated Coverage: Buy | $18 | $12.52 | +43.77% | 1 | Sep 17, 2026 | |
| COO The Cooper Companies | Reiterated: Hold | n/a | $62.93 | - | 11 | Sep 10, 2026 | |
| SOLV Solventum | Reiterated: Buy | $102 | $88.62 | +15.10% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $126.68 | - | 13 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $81 → $92 | $90.98 | +1.12% | 3 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.44 | n/a | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $314.05 | n/a | 3 | Jul 1, 2024 |
ICU Medical
Nov 6, 2026
Reiterated: Buy
Price Target: $164 → $189
Current: $178.26
Upside: +6.02%
Kimball Electronics
Nov 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $19.53
Upside: -
STERIS
Nov 6, 2026
Reiterated: Buy
Price Target: $269 → $284
Current: $256.27
Upside: +10.82%
LeMaitre Vascular
Nov 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $79.29
Upside: -
Inspire Medical Systems
Nov 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $62.11
Upside: -
ResMed
Oct 30, 2026
Reiterated: Buy
Price Target: $267 → $277
Current: $238.53
Upside: +16.13%
Alcon Inc.
Oct 27, 2026
Reiterated: Buy
Price Target: CHF 72.64 → CHF 69.34
Current: CHF 59.48
Upside: +16.57%
NeuroPace
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $12.52
Upside: +43.77%
The Cooper Companies
Sep 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $62.93
Upside: -
Solventum
Aug 6, 2026
Reiterated: Buy
Price Target: $102
Current: $88.62
Upside: +15.10%
Aug 3, 2026
Downgraded: Hold
Price Target: n/a
Current: $126.68
Upside: -
Jun 22, 2026
Rated: Buy
Price Target: $81 → $92
Current: $90.98
Upside: +1.12%
Nov 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $16.44
Upside: n/a
Jul 1, 2024
Reiterated: Hold
Price Target: n/a
Current: $314.05
Upside: n/a